Mylan (MYL) Q1 earnings rose 6% to 66 cents a share, beating views by 3 cents. Sales grew 5% to $1.72 bil, shy of analyst consensus for $1.77 bil. Mylan has been pursuing Swedish pharma Meda, which said Mon. it rejected Mylan's latest offer. Mylan shares fell 2.1% to 49.74.
- Information Technology
- Health Care Industry